MDT
Medtronic plc · Healthcare · Medical - Devices
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.44M | $115.59M | n/a | n/a |
| Q2 2026 | 175 | +1 | 871.51M | $69.43B | +6 | −4 |
| Q1 2026 | 176 | +1 | 881.81M | $77.21B | +3 | −3 |
| Q4 2025 | 174 | 0 | 922.24M | $88.62B | +1 | n/a |
| Q3 2025 | 25 | -2 | 519.60M | $49.51B | n/a | −3 |
| Q2 2025 | 25 | +1 | 407.26M | $35.53B | +1 | n/a |
| Q1 2025 | 21 | 0 | 149.92M | $13.50B | +1 | −1 |
| Q4 2024 | 21 | -1 | 154.76M | $12.40B | n/a | −1 |
| Q3 2024 | 21 | +1 | 104.49M | $9.40B | +1 | n/a |
| Q2 2024 | 20 | n/a | 97.49M | $7.67B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasif) | 26.86M | n/a | $2.11B | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 2 | Wellington Management ✦ | 21.24M | n/a | $1.67B | 0.3% | n/c | 1 | SEC ↗ ×7 |
| 3 | Norges Bank ✦ (pasif) | 15.58M | n/a | $1.23B | 0.2% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 6.98M | n/a | $549.59M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 5 | Dodge & Cox ✦ | 6.79M | n/a | $534.56M | 0.3% | n/c | 1 | SEC ↗ |
| 6 | Fisher Asset Management ✦ | 5.28M | n/a | $415.93M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 4.75M | n/a | $373.52M | 0.3% | n/c | 1 | SEC ↗ |
| 8 | Millennium Management ✦ | 1.99M | n/a | $156.57M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 1.45M | n/a | $113.49M | 0.2% | n/c | 1 | SEC ↗ ×4 |
| 10 | Bridgewater Associates ✦ | 1.38M | n/a | $108.54M | 0.6% | n/c | 1 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 1.10M | n/a | $86.48M | 0.2% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 1.05M | n/a | $82.80M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 870.33K | n/a | $68.50M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 636.34K | n/a | $50.09M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Baillie Gifford ✦ | 432.56K | n/a | $34.05M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 16 | Gotham Asset Management ✦ | 340.67K | n/a | $26.81M | 0.3% | n/c | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 302.45K | n/a | $23.81M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 267.94K | n/a | $21.09M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 19 | D. E. Shaw & Co. ✦ | 190.32K | n/a | $14.98M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 3.92K | n/a | $308,937 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 2,204 pemegang, 1.04B saham, $87.65B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 10.42K lbr · $1.00M
Officer, Director · 50.00K lbr · $4.75M
Officer · 1.48K lbr · $138,883
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi